Skip to main content
Ofer Levy, MD, Pediatric Infectious Disease, Boston, MA

OferLevyMD

Pediatric Infectious Disease Boston, MA

Professor, Pediatrics-Children's Hospital, Harvard Medical School

Dr. Levy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Levy's full profile

Already have an account?

  • Office

    300 Longwood Ave
    Boston, MA 02115
    Phone+1 617-919-2900
    Fax+1 617-730-0255

Summary

  • Dr. Ofer Levy is a pediatric infectious disease specialist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital (BCH) and Brigham and Women's Hospital. He received his medical degree from NYU Grossman School of Medicine and has been in practice 20 years. He directs the Precision Vaccines Program at BCH and serves on the U.S. FDA Vaccines & Related Biologic Products Advisory Committee. He has 180 publications and a Google Scholar H index of 63. Dr. Levy and his research have been featured on CNN, FOXNews, NBC, the New York Times, USA Today and Scientific American.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2000 - 2003
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1997 - 2000
  • New York University School of Medicine
    New York University School of MedicineClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Berson Research Award New York University School of Medicine, 2018

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Increasing FIM2/3 Antigen-Content Improves Efficacy of Bordetella Pertussis Vaccines in Mice in Vivo Without Altering Vaccine-Induced Human Reactogenicity Biomarkers i...  
    Ofer Levy, MD, ScienceDirect

Press Mentions

  • Model Enables Study of Age-Specific Responses to COVID mRNA Vaccines in a Dish
    Model Enables Study of Age-Specific Responses to COVID mRNA Vaccines in a DishDecember 12th, 2024
  • 5 Ways RFK Jr. Could Undermine Lifesaving Childhood Vaccines
    5 Ways RFK Jr. Could Undermine Lifesaving Childhood VaccinesNovember 19th, 2024
  • HMN 2024: In Vitro Model Enables Study of Age-Specific Responses to COVID mRNA Vaccines
    HMN 2024: In Vitro Model Enables Study of Age-Specific Responses to COVID mRNA VaccinesNovember 16th, 2024
  • Join now to see all